Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Based on Lillys stated Q1 2027 filing target, NHS availability is unlikely before 2029 and would almost certainly begin with the highest-need patients
The upcoming Phase I/II clinical trial will test the safety and preliminary efficacy of RJVA-001, a gene therapy designed to locally deliver GLP-1 receptor agonist drugs with the goal of reducing the side effects associated with oral administration
Schedule Your Consultation Today Dr
Why personalization matters Two patients can be on the exact same dose with totally different results
$210 for your 2-month intro bundle ($105/mo) , then $285/mo ongoing
Patients typically start with a lower dose and gradually increase it over several months to reach the 2.4 mg weekly maintenance dose
US$ 20.87
US$ 20.05
US$ 20.70
US$ 27.85
US$ 22.82
US$ 24.19
US$ 23.41
US$ 23.10
US$ 22.94
US$ 25.58
US$ 25.90
US$ 23.48
